Events

events
Conference
December 3, 2019
InSysBio QSP model for BTK inhibitors will be presented at the 61 ASH Annual Meeting
QSP model of BTK inhibitors developed by InSysBio in collaboration with BeiGene will be presented as a poster by Srikumar Sahasranaman from Beigene at 61st American Society of Hematology (ASH) Annual Meeting & Exposition. The model describes marketed BTK inhibitors (ibrutinib and acalabrutinib) and zanubrutinib, a BTK inhibitor which recently received accelerated approval from the FDA as a treatment for mantle cell lymphoma (MCL) in adult patients who have received at least one prior therapy.
LEARN MORE
events
Conference
September 24, 2019
InSysBio to present at SITC 2019
InSysBio announces their participation at 34th Annual Meeting & Pre-Conference Programs on Systems Biology (SITC 2019)
LEARN MORE
events
Conference
September 18, 2019
InSysBio to present at ACoP10
InSysBio announces their participation at Tenth American Conference on Pharmacometrics (ACoP10) to be held October 20th to 23rd, 2019, at the Rosen Shingle Creek Hotel in Orlando, FL.
LEARN MORE
events
Conference
June 5, 2019
InSysBio to present at PAGE 2019
InSysBio announces their participation at PAGE 2019 28th Meeting being held from 11 to 14 June 2019 in Stockholm, Sweden.
LEARN MORE
events
Conference
March 26, 2019
InSysBio to present at PEGS Boston
InSysBio announces their participation at 15th Essential Protein Engineering Summit being held on April 8-12 in Boston, MA.
LEARN MORE
events
Conference
March 22, 2019
InSysBio to present at AACR Annual Meeting 2019
InSysBio announces their participation at American Association for Cancer Research Annual Meeting 2019 being held on March 29 – April 3 in Atlanta, GA
LEARN MORE
June 2022
MoTuWeThFrSaSu
  
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
   
Upcoming Events
25.06
InSysBio to hold a workshop on IRT at PAGE 2024
26.06
InSysBio to take part in PAGE 2024
09.07
InSysBio to participate in JuliaCon2024
Tags